|
|
 | | | |
- close
- close
- close
- close
NASDAQ Biotechnology Index (NBI) |
The Hindu Business Line
May 17
Comment
The NS Raghavan Centre for Entrepreneurial Learning (NSRCEL) at the Indian Institute of Management Bangalore (IIM-B) plans to host the 2013 edition of Next Big Idea (NBI) — a natio...
Benzinga
May 15
Comment
Sucampo Pharmaceuticals (NASDAQ: SCMP) (SPI) today announced that
NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) will include the company in the
NASDAQ Biotechnology Index® (NASDAQ: NBI) effective prior to
market open on Monday, May...
Mondo Visione
May 13
Comment
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index® (Nasdaq:NBI), which will become effective prior to market open on Monday, May 20, 2013.
The following eleven...
MarketWatch
Apr 26
Comment
Biotech stocks have been on a tear of late with big names and indexes at all-time highs, but analysts say it’s no bubble.
TheStreet.com
Apr 2
Comment
BOSTON (TheStreet) -- Biotech stocks continued to march higher at a torrid pace in the first quarter, with the Nasdaq Biotechnology Index (NBI) up 15% compared to a 10% rise in the S&P 500. In fact, the NBI is now comfortably at an all-time high,...
Forbes
Mar 22
Comment
Euphoria in the markets seems like a common theme these days. In fact, this week the NASDAQ Biotech Index (NBI) hit its all time high, even higher than in the 2000 genomics bubble. It’s up 49% since Jan 2012. Add to this the...
Mondo Visione
Nov 12
Comment
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index® (Nasdaq:NBI), which will become effective prior to market open on Monday, November 19, 2012.
The following six...
Globe Newswire
May 21
Comment
CRANBURY, N.J., May 21, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that the Company was added to the NASDAQ
Benzinga
May 15
Comment
Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the Company will be added to the NASDAQ Biotechnology Index® (NBI), effective prior to market open on Monday, May 21, 2012.
The NBI includes biotechnology or pharmaceutical...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
This article describes an index that measures the performance of an exchange, industry or a geographic region. View articles referencing this index. |
| |||||||
